Skip to main content
High RiskFDAfda-F-2130-2012OTHER

Chocolate Chip CLIF Bars, 2.4-oz (68g), individually wrapped, UPC: 7-22252-10090

Units Affected
4,608
Recall Date
August 13, 2012
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2130-2012.

A small amount of Blueberry Crisp CLIF bars were inadvertently placed in Chocolate Chip CLIF bar wrappers and placed inside correctly labeled Blueberry Crisp CLIF bar 12-pack boxes. Retailers sell to consumers in 12-pack boxes, and sometimes as individual bars.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2130-2012.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Clif Bar And Company or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2130-2012.

Clif Bar And Company

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Clif Bar And Company Recall FAQ

Clif Bar And Company is the subject of a snacks & candy safety report: Chocolate Chip CLIF Bars, 2.4-oz (68g), individually wrapped, UPC: 7-22252-10090. The notice was published on August 13, 2012 by the U.S. Food and Drug Administration (FDA). Approximately 4,608 units are potentially affected.